FACHAL, L.,
KAR, S.,
TYRER, J.P.,
GHOUSSAINI, M.,
HARRINGTON, P.A.,
HEALEY, C.S.,
MAYES, R.,
SHAH, M.,
PHAROAH, P.D.P.,
EASTON, D.F.,
DUNNING, A.M.,
ASCHARD, H.,
JIANG, X.,
TAMIMI, R.M.,
KHUSNUTDINOVA, E.,
BIAŁKOWSKA, K.,
и др. соавторы (2020) -associated
signals with the set of credible causal variants in each one. In parallel, we used a Bayesian approach
Yang, L.,
Luo, W.,
Zhang, Q,
Hong, S.,
Wang, Y.,
Samorodov, A.V.,
Chattipakorn, N.,
Pavlov, V.N.,
Liang, G. (2021) secretion in macrophages. We further showed that CAR significantly inhibited NF-κB and JNK
signalingGuan, XX,
Zhang, YW,
Gareev, I,
Beylerli, O,
Li, XY,
Lu, GT,
Lv, L,
Hai, X (2021) demonstrated the relationship between miR-499a and PTEN, with PTEN as a downstream
signaling mediator of mi
in the crosstalk among epigenetic,
signaling, transcriptional and metabolic pathways in TAMs. Particular attention
Beylerli, Ozal,
Tamrazov, Rasim,
Gareev, Ilgiz,
Ilyasova, Tatiana,
Shumadalova, Alina,
Bai, Yunlong,
Yang, Baofeng (2023) to distant sites, where they can modulate gene expression and cell
signaling pathways. They have been shown
Talybov, Rustam,
Beylerli, Ozal,
Mochalov, Vadim,
Prokopenko, Alexey,
Ilyasova, Tatiana,
Trofimova, Tatiana,
Sufianov, Albert,
Guang, Yang (2022) for about 4% of all brain tumors. On neuroimaging, they are characterized by a low MR
signal in T1
Qian, J.,
Zhuang, F.,
Chen, Y.,
Fan, X.,
Wang, J.,
Wang, Z.,
Wang, Y.,
Xu, M.,
Samorodov, A.V.,
Pavlov, V.N.,
Liang, G. (2022) inhibitor C30 completely rescued AMPK
signaling through p38MAPK inhibition. Importantly, C30 treatment
Begliarzade, Sema,
Beilerli, Aferin,
Sufianov, Albert,
Tamrazov, Rasim,
Kudriashov, Valentin,
Ilyasova, Tatiana,
Liang, Yanchao,
Beylerli, Ozal (2023) , metabolism,
signaling
pathways, and apoptosis. LncRNAs molecules are highly stable due to their small size
Pang, HY,
Zhang, WH,
Liang, XW,
Zhang, ZQ,
Chen, XL,
Zhao, LY,
Liu, K,
Galiullin, D,
Yang, K,
Chen, XZ,
Hu, JK (2021) .723–0.786), respectively, which were higher than those of tumor
node metastasis (TNM) staging system alone. The calibration
Gilyazova, Irina,
Ivanova, Elizaveta,
Sinelnikov, Mikhail,
Pavlov, Valentin,
Khusnutdinova, Elza,
Khusnutdinova, Elza,
Beilerli, Aferin,
Mikhaleva, Ludmila,
Liang, Yanchao (2023) to tumor,
node, metastasis (TNM) staging system (p = 0.0256). ROC curve analysis was used to evaluate